Vimian Group
30.00 SEK
-0.79 %
Less than 1K followers
VIMIAN
NASDAQ Stockholm
Health Care Providers
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-0.79 %
+0.67 %
-1.38 %
-29.74 %
-24.62 %
-28.83 %
-6.51 %
-
-61.70 %
Vimian Group is a group active in animal health. Through its subsidiaries, the company delivers medicines and technical solutions to veterinarians, laboratories, and pet owners. The products include, for example, drugs with associated clinical research and digital platforms for veterinary clinics. The company operates worldwide and is headquartered in Stockholm.
Read moreMarket cap
15.86B SEK
Turnover
221.6K SEK
Revenue
4.3B
EBIT %
13.13 %
P/E
65.39
Dividend yield-%
-
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
12/2
2026
Annual report '25
29/4
2026
Interim report Q1'26
29/4
2026
General meeting '26
All
Webcasts
Press releases
ShowingAll content types
Förändring av antalet aktier och röster i Vimian
Vimian Group AB (publ) appoints Alireza Tajbakhsh as CEO
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
